The University of Chicago Header Logo

Connection

Deric Park to Chemoradiotherapy

Back to Details
This is a "connection" page, showing publications Deric Park has written about Chemoradiotherapy.
Deric Park
Connection Strength
0.131
Chemoradiotherapy
  1. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Lett. 2018 02 28; 415:217-226.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.